Drug information for BEPREVE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SOLUTION/DROPS; OPHTHALMIC 1.5% Prescription  (Reference Drug) BEPOTASTINE BESILATE bepotastine besilate ISTA PHARMS 22288
2009-10-21 Review

2009-10-21 Summary Review

2009-09-18 Label

2009-09-16 Letter

Drug Adverse Effects information for BEPREVE

Role code Indications Reaction # Reports
PS BLEPHARITIS DRUG HYPERSENSITIVITY 1
PS BLEPHARITIS LIP SWELLING 1
PS BLEPHARITIS PRURITUS 1
PS BLEPHARITIS RASH ERYTHEMATOUS 1
PS BLEPHARITIS SWOLLEN TONGUE 1
C ASTHMA BURNING SENSATION 1
C ASTHMA DRY EYE 1
C ASTHMA OEDEMA PERIPHERAL 1
C ASTHMA TOOTH EROSION 1
C HYPERSENSITIVITY ERYTHEMA OF EYELID 1
C HYPERSENSITIVITY EYELID OEDEMA 1
C HYPERSENSITIVITY EYELIDS PRURITUS 1
C MADAROSIS ERYTHEMA OF EYELID 1
C MADAROSIS EYELID OEDEMA 1
C MADAROSIS EYELIDS PRURITUS 1
C MULTIPLE SCLEROSIS ALANINE AMINOTRANSFERASE INCREASED 1
C MULTIPLE SCLEROSIS ASPARTATE AMINOTRANSFERASE INCREASED 1
C MULTIPLE SCLEROSIS BLOOD CREATININE INCREASED 1
C MULTIPLE SCLEROSIS BLOOD TRIGLYCERIDES INCREASED 1
C MULTIPLE SCLEROSIS GRANULOCYTE COUNT INCREASED 1
C MULTIPLE SCLEROSIS HEADACHE 1
C MULTIPLE SCLEROSIS HIGH DENSITY LIPOPROTEIN INCREASED 1
C MULTIPLE SCLEROSIS LIVER FUNCTION TEST ABNORMAL 1
C MULTIPLE SCLEROSIS LYMPHOCYTE COUNT INCREASED 1
C MULTIPLE SCLEROSIS MEAN CELL HAEMOGLOBIN DECREASED 1
C MULTIPLE SCLEROSIS UROBILINOGEN URINE INCREASED 1
Ads by Google